Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
In February 2026, Novo Nordisk filed a federal patent infringement suit against Hims & Hers Health, one of the largest telehealth distributors of compounded semaglutide, in the U.S
The drug showed strong blood sugar reduction alongside weight loss
Their continuous R&D investment and extensive global marketing make them the dominant force in the market
Each batch undergoes analytical verification for identity and purity using HPLC and mass spectrometry
US$ 24.59
US$ 29.76
US$ 28.34
US$ 23.95
US$ 20.96
US$ 23.15
US$ 24.60
US$ 22.97
